Back
Veracyte Vs. ProPhase Labs Industry Stock Comparison
Buy
61
VCYT
Veracyte
Last Price:
$40.73
Seasonality Move:
1.06%
Sell
11
PRPH
ProPhase Labs
Last Price:
$0.70
Seasonality Move:
4.58%
Sell
11
ProPhase Labs (PRPH)
is a Sell
Is ProPhase Labs a Buy, Sell or Hold?
-
The current ProPhase Labs [PRPH] share price is $0.65. The Score for PRPH is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
-
PRPH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
VCYT Stock Price Chart
PRPH Stock Price Chart
What is ProPhase Labs's stock price today?
-
The ProPhase Labs share price today is $0.65Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPH is experiencing selling pressure, which indicates risk of future bearish movement.
VCYT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.85 | Buy |
Relative Strength Index (14 RSI): | 42.48 | Sell |
Chaikin Money Flow: | -233519 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.92 - 43.98) | Sell |
Bollinger Bands (100): | (29.23 - 39.75) | Buy |
PRPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.17 | Sell |
Relative Strength Index (14 RSI): | 26.42 | Sell |
Chaikin Money Flow: | -77260 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.68 - 0.78) | Sell |
Bollinger Bands (100): | (1.15 - 2.79) | Sell |
VCYT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.29 | Sell |
20-day SMA: | 42.41 | Sell |
50-day SMA: | 38.1 | Buy |
200-day SMA: | 28.01 | Buy |
8-day EMA: | 41.58 | Sell |
20-day EMA: | 41.5 | Sell |
50-day EMA: | 38.79 | Buy |
200-day EMA: | 31.08 | Buy |
PRPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.67 | Sell |
20-day SMA: | 0.72 | Sell |
50-day SMA: | 1.37 | Sell |
200-day SMA: | 3.42 | Sell |
8-day EMA: | 0.68 | Sell |
20-day EMA: | 0.79 | Sell |
50-day EMA: | 1.25 | Sell |
200-day EMA: | 2.95 | Sell |
Veracyte Earnings Growth & VCYT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.24 per share, and a decrease next year of $0.12 per share.
ProPhase Labs Earnings Growth & PRPH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and an increase next year of $0.43 per share.
Veracyte Technical Analysis
Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ProPhase Labs Technical Analysis
Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |